Description
| Product Name: | Recombinant Human B7-2/CD86 (C-Avi-6His) Biotinylated |
| Product Code: | RPES6347 |
| Size: | 20µg |
| Species: | Human |
| Expression Host: | HEK293 Cells |
| Synonyms: | T-Lymphocyte Activation Antigen CD86, Activation B7-2 Antigen, B70, BU63, CTLA-4 Counter-Receptor B7.2, FUN-1, CD86, CD28LG2 |
| Mol Mass: | 28.4 kDa |
| AP Mol Mass: | 55-80 kDa |
| Tag: | C-Avi-6His |
| Purity: | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin Level: | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Bio Activity: | Testing in progress |
| Sequence: | Ala24-Pro247 |
| Accession: | AAH40261.1 |
| Storage: | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| Shipping: | This product is provided as lyophilized powder which is shipped with ice packs. |
| Formulation: | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed man |
| Reconstitution: | Please refer to the printed manual for detailed information. |
| Background: | The protein is the receptor that involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. It may play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation. The protein interacts with MARCH8, human herpesvirus 8 MIR2 protein, adenovirus subgroup B fiber proteins and acts as a receptor for these viruses.It is expressed by activated B-lymphocytes and monocytes and promoted by MARCH8 and results in endocytosis and lysosomal degradation.It contains 1 Ig-like C2-type(immunoglobulin-like) domainand 1 Ig-like V-type (immunoglobulin-like) domain. |
Related Products
Recombinant Human FGL1 (C-Avi-6His) Biotinylated
OverviewProduct Name:Recombinant Human FGL1 (C-Avi-6His) BiotinylatedProduct Code:RPES6208Size:20µgSpecies:Human
Recombinant Human CD79B/B29 (C-6His-Avi) Biotinylated
OverviewProduct Name:Recombinant Human CD79B/B29 (C-6His-Avi) BiotinylatedProduct Code:RPES6291Size:20µgSpecies:Human
Recombinant Human IL-5 (C-6His-Avi) Biotinylated
OverviewProduct Name:Recombinant Human IL-5 (C-6His-Avi) BiotinylatedProduct Code:RPES6389Size:20µgSpecies:Human
Recombinant Human Frizzled-8 (C-6His-Avi) Biotinylated
OverviewProduct Name:Recombinant Human Frizzled-8 (C-6His-Avi) BiotinylatedProduct Code:RPES6391Size:20µgSpecies:Human<
Recombinant Human TPBG/5T4 (C-Avi-6His) Biotinylated
OverviewProduct Name:Recombinant Human TPBG/5T4 (C-Avi-6His) BiotinylatedProduct Code:RPES6240Size:20µgSpecies:Human